| Company Name: | Reliv' International, Inc. | | Ticker Symbol: | RELV | | | WWW Address: | www.reliv.com |
| CEO: | Robert L. Montgomery | | No. of Employees: | 214 |
| Common Issue Type: | CS | | Business Description: | Reliv' International, Inc., is a developer, manufacturer and marketer of a proprietary line of nutritional supplements addressing basic nutrition, specific wellness needs, weight management and sports nutrition.
|
| | | Industry Information: | DRUGS - Biotechnology [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 1.32 |  -0.0001 | 1.32 | 1.33 | 1.24 | 1.35 | 1.35 | 7727 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 16.7 | 12.6 | 0.16 | 0.11 | 0.03 | 15.0 | 3.0 | 1.88 - 1.15 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 1.35 | $ | | PE Ratio - LTM | 15.0 | |
| Market Capitalisation | 16.7 | mil |
| Latest Shares Outstanding | 12.6 | mil |
| Earnings pS (EPS) | 0.11 | $ |
| Dividend pS (DPS) | 0.03 | ¢ |
| Dividend Yield | 3.0 | % |
| Dividend Payout Ratio | 27 | % |
| Revenue per Employee | 321,074 | $ |
| Effective Tax Rate | 36.7 | % |
| Float | 8.0 | mil |
| Float as % of Shares Outstanding | 63.0 | % |
| Foreign Sales | 15 | mil |
| Domestic Sales | 54 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 78.00 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 81.2 | % |
| EBITDA Margin | 3.2 | % |
| Pre-Tax Profit Margin | 2.5 | % |
| Assets Turnover | 2.6 | % |
| Return on Assets (ROA) | 6.3 | % |
| Return on Equity (ROE) | 10.5 | % |
| Return on Capital Invested (ROCI) | 9.2 | % |
| Current Ratio | 1.8 | |
| Leverage Ratio (Assets/Equity) | 1.7 | |
| Interest Cover | 28.2 | |
| Total Debt/Equity (Gearing Ratio) | 0.18 | |
| LT Debt/Total Capital | 13.0 | % |
| Working Capital pS | 0.47 | $ |
| Cash pS | 0.46 | $ |
| Book-Value pS | 1.25 | $ |
| Tangible Book-Value pS | 1.14 | $ |
| Cash Flow pS | 0.21 | $ |
| Free Cash Flow pS | 0.01 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 1.08 | |
| Price/Tangible Book Ratio | 1.19 | |
| Price/Cash Flow | 6.6 | |
| Price/Free Cash Flow | 160.5 | |
| P/E as % of Industry Group | 56.0 | % |
| P/E as % of Sector Segment | 11.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Dividend Declared Date | 05/07/2013 |
| Dividend Ex-Date | 05/15/2013 |
| Dividend Record Date | 05/19/2013 |
| Dividend Pay Date | 05/29/2013 |
| Dividend Amount | 20 |
| Type of Payment | Cash Payment |
| Dividend Rate | 0.04 |
| Current Dividend Yield | 3.0 |
| 5-Y Average Dividend Yield | 1.7 |
| Payout Ratio | 27.0 |
| 5-Y Average Payout Ratio | 39.0 |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | -2.2 | 98 | 55 | 68 |
| 4 Weeks | 1.44 | 1.26 | 1.26 | 7.1 | 109 | 92 | 1,662 |
| 13 Weeks | 1.44 | 1.18 | 1.18 | 14.1 | 109 | 76 | 4,689 |
| 26 Weeks | 1.45 | 1.15 | 1.24 | 8.9 | 94 | 98 | 12,081 |
| 52 Weeks | 1.88 | 1.15 | 1.78 | -24.2 | 62 | 80 | 19,861 |
| YTD | 1.44 | 1.15 | - | 3.1 | 90 | 100 | 11,346 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 1.38 | 1.38 | 1.31 | 1.28 | 1.29 | 0.16 | 0.86 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | -7.92 | 97.1 | -6.08 |
| Income | -17.57 | 78.4 | -17.28 |
| Dividend | -22.69 | 91.8 | -19.62 |
| Capital Spending | -1.34 | NA | 10.98 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | -17.57 | NA | -17.28 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | -4.5 | -4.5 | -7.0 |
| Earnings % | -63.4 | -63.4 | 29.7 |
| EPS % | -50.0 | -50.0 | 37.5 |
| EPS $ | -0.02 | -0.02 | 0.03 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 23.26 |
| Current Ratio | 1.9 |
| Quick Ratio (Acid Test) | 0.9 |
| Liquidity Ratio (Cash) | 0.88 |
| Receivables Turnover | 163.3 |
| Average Collection Period | 2 |
| Working Capital/Equity | 37.7 |
| Working Capital pS | 0.47 |
| Cash-Flow pS | 0.18 |
| Free Cash-Flow pS | 0.10 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 4.42 |
| Financial Leverage Ratio (Assets/Equity) | 1.6 |
| Debt Ratio | 38.3 |
| Total Debt/Equity (Gearing Ratio) | 0.19 |
| LT Debt/Equity | 0.15 |
| LT Debt/Capital Invested | 17.0 |
| LT Debt/Total Liabilities | 24.8 |
| Interest Cover | 22.6 |
| Interest/Capital Invested | 0.53 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 1.34 |
| Tobin's Q Ratio | 0.67 |
| Current P/E Ratio - LTM | 15.00 |
| Enterprise Value (EV)/EBITDA | 7.84 |
| Enterprise Value (EV)/Free Cash Flow | 63.10 |
| Dividend Yield | 3.0 |
| Price/Tangible Book Ratio - LTM | 1.19 |
| Price/Book Ratio - LTM | 1.08 |
| Price/Cash Flow Ratio | 6.6 |
| Price/Free Cash Flow Ratio - LTM | 160.5 |
| Price/Sales Ratio | 0.25 |
| P/E Ratio (1 month ago) - LTM | 14.7 |
| P/E Ratio (26 weeks ago) - LTM | 13.8 |
| P/E Ratio (52 weeks ago) - LTM | 25.4 |
| 5-Y High P/E Ratio | 46.1 |
| 5-Y Low P/E Ratio | 10.4 |
| 5-Y Average P/E Ratio | 16.2 |
| Current P/E Ratio as % of 5-Y Average P/E | 92 |
| P/E as % of Industry Group | 56.0 |
| P/E as % of Sector Segment | 11.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 15.0 |
| PER SHARE FIGURES |
| LT Debt pS | 0.19 |
| Current Liabilities pS | 0.52 |
| Tangible Book Value pS - LTM | 1.14 |
| Book Value pS - LTM | 1.25 |
| Capital Invested pS | 1.43 |
| Cash pS - LTM | 0.46 |
| Cash Flow pS - LTM | 0.21 |
| Free Cash Flow pS - LTM | 0.01 |
| Earnings pS (EPS) | 0.11 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 1.84 |
| Free Cash Flow Margin 5YEAR AVG | 2.25 |
| Net Profit Margin | 2.0 |
| Net Profit Margin - 5YEAR AVRG. | 2.3 |
| Equity Productivity | 4.41 |
| Return on Equity (ROE) | 8.7 |
| Return on Equity (ROE) - 5YEAR AVRG. | 13.1 |
| Capital Invested Productivity | 3.82 |
| Return on Capital Invested (ROCI) | 7.6 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 10.9 |
| Assets Productivity | 2.80 |
| Return on Assets (ROA) | 5.4 |
| Return on Assets (ROA) - 5YEAR AVRG. | 7.7 |
| Gross Profit Margin | 81.2 |
| Gross Profit Margin - 5YEAR AVRG. | 81.9 |
| EBITDA Margin - LTM | 3.2 |
| EBIT Margin - LTM | 2.6 |
| Pre-Tax Profit Margin | 3.1 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 4.0 |
| Effective Tax Rate | 36.7 |
| Effective Tax Rate - 5YEAR AVRG. | 39.6 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 143 |
| Revenue per Employee | 321,074 |
| Net Income per Employee | 6,350 |
| Average Collection Period | 2 |
| Receivables Turnover | 163.3 |
| Day's Inventory Turnover Ratio | 141 |
| Inventory Turnover | 2.5 |
| Inventory/Sales | 7.7 |
| Accounts Payble/Sales | 4.26 |
| Assets/Revenue | 0.36 |
| Net Working Capital Turnover | 11.69 |
| Fixed Assets Turnover | 5.38 |
| Total Assets Turnover | 2.8 |
| Revenue per $ Cash | 11.84 |
| Revenue per $ Plant | 9.66 |
| Revenue per $ Common Equity | 4.41 |
| Revenue per $ Capital Invested | 3.82 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 77.6 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 76.6 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
|
| |
 |  |
